BlackRock Global Allocation Fund
BlackRock Global Allocation Fund (MDLOX) Stock Competitors & Peer Comparison
See (MDLOX) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management - Global Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDLOX | $19.81 | -0.55% | 16.5B | N/A | N/A | N/A |
| APO | $133.89 | -0.23% | 76.6B | 25.03 | $5.35 | +1.45% |
| FESGX | $75.66 | +0.99% | 62.2B | 19.23 | $3.96 | N/A |
| FEGRX | $80.29 | +0.99% | 62.2B | 18.75 | $4.31 | N/A |
| SGIIX | $80.24 | +0.99% | 62.2B | 19.29 | $4.19 | N/A |
| SGENX | $79.64 | +0.99% | 62.2B | 18.75 | $4.27 | N/A |
| APO-PA | $70.90 | -0.31% | 40.6B | 8.53 | $8.32 | +1.45% |
| GBLEX | $40.46 | +0.47% | 28.2B | 21.03 | $1.93 | N/A |
| AGVEX | $26.88 | +0.60% | 17.6B | 27.04 | $1.00 | N/A |
| FSGGX | $17.71 | +0.51% | 13.2B | N/A | N/A | N/A |
Stock Comparison
MDLOX vs APO Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, APO has a market cap of 76.6B. Regarding current trading prices, MDLOX is priced at $19.81, while APO trades at $133.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APO's P/E ratio is 25.03. In terms of profitability, MDLOX's ROE is N/A, compared to APO's ROE of +0.19%. Regarding short-term risk, MDLOX is less volatile compared to APO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check APO's competition here
MDLOX vs FESGX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, FESGX has a market cap of 62.2B. Regarding current trading prices, MDLOX is priced at $19.81, while FESGX trades at $75.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FESGX's P/E ratio is 19.23. In terms of profitability, MDLOX's ROE is N/A, compared to FESGX's ROE of N/A. Regarding short-term risk, MDLOX and FESGX have similar daily volatility (0.00).Check FESGX's competition here
MDLOX vs FEGRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, FEGRX has a market cap of 62.2B. Regarding current trading prices, MDLOX is priced at $19.81, while FEGRX trades at $80.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FEGRX's P/E ratio is 18.75. In terms of profitability, MDLOX's ROE is N/A, compared to FEGRX's ROE of N/A. Regarding short-term risk, MDLOX and FEGRX have similar daily volatility (0.00).Check FEGRX's competition here
MDLOX vs SGIIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, SGIIX has a market cap of 62.2B. Regarding current trading prices, MDLOX is priced at $19.81, while SGIIX trades at $80.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGIIX's P/E ratio is 19.29. In terms of profitability, MDLOX's ROE is N/A, compared to SGIIX's ROE of N/A. Regarding short-term risk, MDLOX and SGIIX have similar daily volatility (0.00).Check SGIIX's competition here
MDLOX vs SGENX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, SGENX has a market cap of 62.2B. Regarding current trading prices, MDLOX is priced at $19.81, while SGENX trades at $79.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGENX's P/E ratio is 18.75. In terms of profitability, MDLOX's ROE is N/A, compared to SGENX's ROE of N/A. Regarding short-term risk, MDLOX and SGENX have similar daily volatility (0.00).Check SGENX's competition here
MDLOX vs APO-PA Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, APO-PA has a market cap of 40.6B. Regarding current trading prices, MDLOX is priced at $19.81, while APO-PA trades at $70.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APO-PA's P/E ratio is 8.53. In terms of profitability, MDLOX's ROE is N/A, compared to APO-PA's ROE of +0.19%. Regarding short-term risk, MDLOX is less volatile compared to APO-PA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check APO-PA's competition here
MDLOX vs GBLEX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, GBLEX has a market cap of 28.2B. Regarding current trading prices, MDLOX is priced at $19.81, while GBLEX trades at $40.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GBLEX's P/E ratio is 21.03. In terms of profitability, MDLOX's ROE is N/A, compared to GBLEX's ROE of N/A. Regarding short-term risk, MDLOX and GBLEX have similar daily volatility (0.00).Check GBLEX's competition here
MDLOX vs AGVEX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, AGVEX has a market cap of 17.6B. Regarding current trading prices, MDLOX is priced at $19.81, while AGVEX trades at $26.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas AGVEX's P/E ratio is 27.04. In terms of profitability, MDLOX's ROE is N/A, compared to AGVEX's ROE of N/A. Regarding short-term risk, MDLOX and AGVEX have similar daily volatility (0.00).Check AGVEX's competition here
MDLOX vs FSGGX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, FSGGX has a market cap of 13.2B. Regarding current trading prices, MDLOX is priced at $19.81, while FSGGX trades at $17.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FSGGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FSGGX's ROE of N/A. Regarding short-term risk, MDLOX and FSGGX have similar daily volatility (0.00).Check FSGGX's competition here
MDLOX vs GLFOX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, GLFOX has a market cap of 10.4B. Regarding current trading prices, MDLOX is priced at $19.81, while GLFOX trades at $17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GLFOX's P/E ratio is 18.47. In terms of profitability, MDLOX's ROE is N/A, compared to GLFOX's ROE of N/A. Regarding short-term risk, MDLOX and GLFOX have similar daily volatility (0.00).Check GLFOX's competition here
MDLOX vs GLIFX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, GLIFX has a market cap of 10.4B. Regarding current trading prices, MDLOX is priced at $19.81, while GLIFX trades at $17.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GLIFX's P/E ratio is 16.41. In terms of profitability, MDLOX's ROE is N/A, compared to GLIFX's ROE of N/A. Regarding short-term risk, MDLOX and GLIFX have similar daily volatility (0.00).Check GLIFX's competition here
MDLOX vs PAVE Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PAVE has a market cap of 9B. Regarding current trading prices, MDLOX is priced at $19.81, while PAVE trades at $46.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PAVE's P/E ratio is 27.59. In terms of profitability, MDLOX's ROE is N/A, compared to PAVE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PAVE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check PAVE's competition here
MDLOX vs AAM-PB Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, AAM-PB has a market cap of 8.8B. Regarding current trading prices, MDLOX is priced at $19.81, while AAM-PB trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas AAM-PB's P/E ratio is 40.26. In terms of profitability, MDLOX's ROE is N/A, compared to AAM-PB's ROE of +0.19%. Regarding short-term risk, MDLOX is less volatile compared to AAM-PB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check AAM-PB's competition here
MDLOX vs AAM-PA Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, AAM-PA has a market cap of 8.8B. Regarding current trading prices, MDLOX is priced at $19.81, while AAM-PA trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas AAM-PA's P/E ratio is 40.26. In terms of profitability, MDLOX's ROE is N/A, compared to AAM-PA's ROE of +0.19%. Regarding short-term risk, MDLOX is less volatile compared to AAM-PA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check AAM-PA's competition here
MDLOX vs JATSX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JATSX has a market cap of 8.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JATSX trades at $66.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATSX's ROE of N/A. Regarding short-term risk, MDLOX and JATSX have similar daily volatility (0.00).Check JATSX's competition here
MDLOX vs JATNX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JATNX has a market cap of 8.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JATNX trades at $73.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATNX's ROE of N/A. Regarding short-term risk, MDLOX and JATNX have similar daily volatility (0.00).Check JATNX's competition here
MDLOX vs JAGTX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JAGTX has a market cap of 8.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JAGTX trades at $71.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAGTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGTX's ROE of N/A. Regarding short-term risk, MDLOX and JAGTX have similar daily volatility (0.00).Check JAGTX's competition here
MDLOX vs JATIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JATIX has a market cap of 8.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JATIX trades at $74.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATIX's ROE of N/A. Regarding short-term risk, MDLOX and JATIX have similar daily volatility (0.00).Check JATIX's competition here
MDLOX vs JNGTX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JNGTX has a market cap of 8.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JNGTX trades at $73.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JNGTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JNGTX's ROE of N/A. Regarding short-term risk, MDLOX and JNGTX have similar daily volatility (0.00).Check JNGTX's competition here
MDLOX vs JATAX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JATAX has a market cap of 8.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JATAX trades at $69.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JATAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATAX's ROE of N/A. Regarding short-term risk, MDLOX and JATAX have similar daily volatility (0.00).Check JATAX's competition here
MDLOX vs JAGCX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JAGCX has a market cap of 8.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JAGCX trades at $56.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAGCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGCX's ROE of N/A. Regarding short-term risk, MDLOX and JAGCX have similar daily volatility (0.00).Check JAGCX's competition here
MDLOX vs QYLD Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, QYLD has a market cap of 8.3B. Regarding current trading prices, MDLOX is priced at $19.81, while QYLD trades at $16.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas QYLD's P/E ratio is 32.85. In terms of profitability, MDLOX's ROE is N/A, compared to QYLD's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to QYLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check QYLD's competition here
MDLOX vs VHGEX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, VHGEX has a market cap of 7.9B. Regarding current trading prices, MDLOX is priced at $19.81, while VHGEX trades at $41.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VHGEX's P/E ratio is 23.22. In terms of profitability, MDLOX's ROE is N/A, compared to VHGEX's ROE of +0.00%. Regarding short-term risk, MDLOX and VHGEX have similar daily volatility (0.00).Check VHGEX's competition here
MDLOX vs PAGSX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PAGSX has a market cap of 7B. Regarding current trading prices, MDLOX is priced at $19.81, while PAGSX trades at $68.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PAGSX's P/E ratio is 27.05. In terms of profitability, MDLOX's ROE is N/A, compared to PAGSX's ROE of N/A. Regarding short-term risk, MDLOX and PAGSX have similar daily volatility (0.00).Check PAGSX's competition here
MDLOX vs PRGSX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PRGSX has a market cap of 7B. Regarding current trading prices, MDLOX is priced at $19.81, while PRGSX trades at $69.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRGSX's P/E ratio is 28.56. In terms of profitability, MDLOX's ROE is N/A, compared to PRGSX's ROE of N/A. Regarding short-term risk, MDLOX and PRGSX have similar daily volatility (0.00).Check PRGSX's competition here
MDLOX vs DFGEX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, DFGEX has a market cap of 7B. Regarding current trading prices, MDLOX is priced at $19.81, while DFGEX trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas DFGEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DFGEX's ROE of N/A. Regarding short-term risk, MDLOX and DFGEX have similar daily volatility (0.00).Check DFGEX's competition here
MDLOX vs PGGFX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PGGFX has a market cap of 6.7B. Regarding current trading prices, MDLOX is priced at $19.81, while PGGFX trades at $25.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PGGFX's P/E ratio is 24.30. In terms of profitability, MDLOX's ROE is N/A, compared to PGGFX's ROE of N/A. Regarding short-term risk, MDLOX and PGGFX have similar daily volatility (0.00).Check PGGFX's competition here
MDLOX vs CGGO Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CGGO has a market cap of 6.5B. Regarding current trading prices, MDLOX is priced at $19.81, while CGGO trades at $32.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CGGO's P/E ratio is 24.65. In terms of profitability, MDLOX's ROE is N/A, compared to CGGO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CGGO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check CGGO's competition here
MDLOX vs PRJQX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PRJQX has a market cap of 6.3B. Regarding current trading prices, MDLOX is priced at $19.81, while PRJQX trades at $47.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRJQX's P/E ratio is 42.80. In terms of profitability, MDLOX's ROE is N/A, compared to PRJQX's ROE of N/A. Regarding short-term risk, MDLOX and PRJQX have similar daily volatility (0.00).Check PRJQX's competition here
MDLOX vs PRJZX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PRJZX has a market cap of 6.3B. Regarding current trading prices, MDLOX is priced at $19.81, while PRJZX trades at $47.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRJZX's P/E ratio is 42.79. In terms of profitability, MDLOX's ROE is N/A, compared to PRJZX's ROE of N/A. Regarding short-term risk, MDLOX and PRJZX have similar daily volatility (0.00).Check PRJZX's competition here
MDLOX vs ACWV Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, ACWV has a market cap of 6.2B. Regarding current trading prices, MDLOX is priced at $19.81, while ACWV trades at $119.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas ACWV's P/E ratio is 19.20. In terms of profitability, MDLOX's ROE is N/A, compared to ACWV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ACWV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check ACWV's competition here
MDLOX vs PRGTX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PRGTX has a market cap of 5B. Regarding current trading prices, MDLOX is priced at $19.81, while PRGTX trades at $24.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PRGTX's P/E ratio is 45.03. In terms of profitability, MDLOX's ROE is N/A, compared to PRGTX's ROE of +0.14%. Regarding short-term risk, MDLOX and PRGTX have similar daily volatility (0.00).Check PRGTX's competition here
MDLOX vs IOO Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, IOO has a market cap of 4.9B. Regarding current trading prices, MDLOX is priced at $19.81, while IOO trades at $114.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas IOO's P/E ratio is 26.74. In terms of profitability, MDLOX's ROE is N/A, compared to IOO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IOO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check IOO's competition here
MDLOX vs GUNR Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, GUNR has a market cap of 4.8B. Regarding current trading prices, MDLOX is priced at $19.81, while GUNR trades at $42.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GUNR's P/E ratio is 16.96. In terms of profitability, MDLOX's ROE is N/A, compared to GUNR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GUNR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check GUNR's competition here
MDLOX vs JAWWX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JAWWX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JAWWX trades at $125.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAWWX's P/E ratio is 3.29. In terms of profitability, MDLOX's ROE is N/A, compared to JAWWX's ROE of N/A. Regarding short-term risk, MDLOX and JAWWX have similar daily volatility (0.00).Check JAWWX's competition here
MDLOX vs JWWCX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JWWCX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JWWCX trades at $121.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JWWCX's P/E ratio is 3.17. In terms of profitability, MDLOX's ROE is N/A, compared to JWWCX's ROE of N/A. Regarding short-term risk, MDLOX and JWWCX have similar daily volatility (0.00).Check JWWCX's competition here
MDLOX vs JWGRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JWGRX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JWGRX trades at $128.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JWGRX's P/E ratio is 3.36. In terms of profitability, MDLOX's ROE is N/A, compared to JWGRX's ROE of N/A. Regarding short-term risk, MDLOX and JWGRX have similar daily volatility (0.00).Check JWGRX's competition here
MDLOX vs JDWAX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JDWAX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JDWAX trades at $127.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JDWAX's P/E ratio is 3.34. In terms of profitability, MDLOX's ROE is N/A, compared to JDWAX's ROE of N/A. Regarding short-term risk, MDLOX and JDWAX have similar daily volatility (0.00).Check JDWAX's competition here
MDLOX vs JWWFX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JWWFX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JWWFX trades at $128.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JWWFX's P/E ratio is 3.37. In terms of profitability, MDLOX's ROE is N/A, compared to JWWFX's ROE of N/A. Regarding short-term risk, MDLOX and JWWFX have similar daily volatility (0.00).Check JWWFX's competition here
MDLOX vs JDWRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JDWRX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JDWRX trades at $125.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JDWRX's P/E ratio is 3.28. In terms of profitability, MDLOX's ROE is N/A, compared to JDWRX's ROE of N/A. Regarding short-term risk, MDLOX and JDWRX have similar daily volatility (0.00).Check JDWRX's competition here
MDLOX vs JDWNX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JDWNX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JDWNX trades at $125.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JDWNX's P/E ratio is 17.36. In terms of profitability, MDLOX's ROE is N/A, compared to JDWNX's ROE of N/A. Regarding short-term risk, MDLOX and JDWNX have similar daily volatility (0.00).Check JDWNX's competition here
MDLOX vs JAGLX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JAGLX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JAGLX trades at $68.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JAGLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGLX's ROE of N/A. Regarding short-term risk, MDLOX and JAGLX have similar daily volatility (0.00).Check JAGLX's competition here
MDLOX vs JFNSX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JFNSX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JFNSX trades at $64.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNSX's ROE of N/A. Regarding short-term risk, MDLOX and JFNSX have similar daily volatility (0.00).Check JFNSX's competition here
MDLOX vs JFNNX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JFNNX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JFNNX trades at $68.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNNX's ROE of N/A. Regarding short-term risk, MDLOX and JFNNX have similar daily volatility (0.00).Check JFNNX's competition here
MDLOX vs JFNCX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JFNCX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JFNCX trades at $57.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNCX's ROE of N/A. Regarding short-term risk, MDLOX and JFNCX have similar daily volatility (0.00).Check JFNCX's competition here
MDLOX vs JFNAX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JFNAX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JFNAX trades at $66.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNAX's ROE of N/A. Regarding short-term risk, MDLOX and JFNAX have similar daily volatility (0.00).Check JFNAX's competition here
MDLOX vs JFNIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JFNIX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JFNIX trades at $68.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JFNIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNIX's ROE of N/A. Regarding short-term risk, MDLOX and JFNIX have similar daily volatility (0.00).Check JFNIX's competition here
MDLOX vs JNGLX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JNGLX has a market cap of 4.3B. Regarding current trading prices, MDLOX is priced at $19.81, while JNGLX trades at $68.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JNGLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JNGLX's ROE of N/A. Regarding short-term risk, MDLOX and JNGLX have similar daily volatility (0.00).Check JNGLX's competition here
MDLOX vs URA Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, URA has a market cap of 4.2B. Regarding current trading prices, MDLOX is priced at $19.81, while URA trades at $39.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas URA's P/E ratio is 30.29. In terms of profitability, MDLOX's ROE is N/A, compared to URA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to URA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check URA's competition here
MDLOX vs CTCAX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CTCAX has a market cap of 4B. Regarding current trading prices, MDLOX is priced at $19.81, while CTCAX trades at $98.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTCAX's P/E ratio is 37.36. In terms of profitability, MDLOX's ROE is N/A, compared to CTCAX's ROE of N/A. Regarding short-term risk, MDLOX and CTCAX have similar daily volatility (0.00).Check CTCAX's competition here
MDLOX vs CMTFX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CMTFX has a market cap of 4B. Regarding current trading prices, MDLOX is priced at $19.81, while CMTFX trades at $104.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CMTFX's P/E ratio is 37.36. In terms of profitability, MDLOX's ROE is N/A, compared to CMTFX's ROE of N/A. Regarding short-term risk, MDLOX and CMTFX have similar daily volatility (0.00).Check CMTFX's competition here
MDLOX vs CTHCX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CTHCX has a market cap of 4B. Regarding current trading prices, MDLOX is priced at $19.81, while CTHCX trades at $83.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTHCX's P/E ratio is 37.34. In terms of profitability, MDLOX's ROE is N/A, compared to CTHCX's ROE of N/A. Regarding short-term risk, MDLOX and CTHCX have similar daily volatility (0.00).Check CTHCX's competition here
MDLOX vs CTHRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CTHRX has a market cap of 4B. Regarding current trading prices, MDLOX is priced at $19.81, while CTHRX trades at $107.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTHRX's P/E ratio is 37.37. In terms of profitability, MDLOX's ROE is N/A, compared to CTHRX's ROE of N/A. Regarding short-term risk, MDLOX and CTHRX have similar daily volatility (0.00).Check CTHRX's competition here
MDLOX vs CGTUX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CGTUX has a market cap of 4B. Regarding current trading prices, MDLOX is priced at $19.81, while CGTUX trades at $107.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CGTUX's P/E ratio is 37.37. In terms of profitability, MDLOX's ROE is N/A, compared to CGTUX's ROE of N/A. Regarding short-term risk, MDLOX and CGTUX have similar daily volatility (0.00).Check CGTUX's competition here
MDLOX vs REET Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, REET has a market cap of 3.8B. Regarding current trading prices, MDLOX is priced at $19.81, while REET trades at $25.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas REET's P/E ratio is 25.94. In terms of profitability, MDLOX's ROE is N/A, compared to REET's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to REET. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check REET's competition here
MDLOX vs VNQI Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, VNQI has a market cap of 3.7B. Regarding current trading prices, MDLOX is priced at $19.81, while VNQI trades at $47.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VNQI's P/E ratio is 15.12. In terms of profitability, MDLOX's ROE is N/A, compared to VNQI's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to VNQI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check VNQI's competition here
MDLOX vs CTYRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CTYRX has a market cap of 3.7B. Regarding current trading prices, MDLOX is priced at $19.81, while CTYRX trades at $92.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CTYRX's P/E ratio is 37.78. In terms of profitability, MDLOX's ROE is N/A, compared to CTYRX's ROE of N/A. Regarding short-term risk, MDLOX and CTYRX have similar daily volatility (0.00).Check CTYRX's competition here
MDLOX vs DGSIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, DGSIX has a market cap of 3.6B. Regarding current trading prices, MDLOX is priced at $19.81, while DGSIX trades at $22.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas DGSIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DGSIX's ROE of N/A. Regarding short-term risk, MDLOX and DGSIX have similar daily volatility (0.00).Check DGSIX's competition here
MDLOX vs BGHIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, BGHIX has a market cap of 3.6B. Regarding current trading prices, MDLOX is priced at $19.81, while BGHIX trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas BGHIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to BGHIX's ROE of N/A. Regarding short-term risk, MDLOX and BGHIX have similar daily volatility (0.00).Check BGHIX's competition here
MDLOX vs MGGIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, MGGIX has a market cap of 3.4B. Regarding current trading prices, MDLOX is priced at $19.81, while MGGIX trades at $39.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MGGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGGIX's ROE of N/A. Regarding short-term risk, MDLOX and MGGIX have similar daily volatility (0.00).Check MGGIX's competition here
MDLOX vs MGGPX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, MGGPX has a market cap of 3.4B. Regarding current trading prices, MDLOX is priced at $19.81, while MGGPX trades at $37.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MGGPX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGGPX's ROE of N/A. Regarding short-term risk, MDLOX and MGGPX have similar daily volatility (0.00).Check MGGPX's competition here
MDLOX vs GNR Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, GNR has a market cap of 3.2B. Regarding current trading prices, MDLOX is priced at $19.81, while GNR trades at $57.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GNR's P/E ratio is 17.78. In terms of profitability, MDLOX's ROE is N/A, compared to GNR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GNR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check GNR's competition here
MDLOX vs IXJ Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, IXJ has a market cap of 3.1B. Regarding current trading prices, MDLOX is priced at $19.81, while IXJ trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas IXJ's P/E ratio is 24.52. In terms of profitability, MDLOX's ROE is N/A, compared to IXJ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IXJ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check IXJ's competition here
MDLOX vs XYLD Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, XYLD has a market cap of 3.1B. Regarding current trading prices, MDLOX is priced at $19.81, while XYLD trades at $38.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas XYLD's P/E ratio is 26.78. In terms of profitability, MDLOX's ROE is N/A, compared to XYLD's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to XYLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check XYLD's competition here
MDLOX vs LGMAX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, LGMAX has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.81, while LGMAX trades at $26.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas LGMAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LGMAX's ROE of N/A. Regarding short-term risk, MDLOX and LGMAX have similar daily volatility (0.00).Check LGMAX's competition here
MDLOX vs LSWWX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, LSWWX has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.81, while LSWWX trades at $26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas LSWWX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LSWWX's ROE of N/A. Regarding short-term risk, MDLOX and LSWWX have similar daily volatility (0.00).Check LSWWX's competition here
MDLOX vs LGMCX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, LGMCX has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.81, while LGMCX trades at $24.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas LGMCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LGMCX's ROE of N/A. Regarding short-term risk, MDLOX and LGMCX have similar daily volatility (0.00).Check LGMCX's competition here
MDLOX vs BOTZ Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, BOTZ has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.81, while BOTZ trades at $33.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas BOTZ's P/E ratio is 33.70. In terms of profitability, MDLOX's ROE is N/A, compared to BOTZ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BOTZ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check BOTZ's competition here
MDLOX vs NFRA Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, NFRA has a market cap of 2.8B. Regarding current trading prices, MDLOX is priced at $19.81, while NFRA trades at $62.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas NFRA's P/E ratio is 18.03. In terms of profitability, MDLOX's ROE is N/A, compared to NFRA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to NFRA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check NFRA's competition here
MDLOX vs APDGX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, APDGX has a market cap of 2.7B. Regarding current trading prices, MDLOX is priced at $19.81, while APDGX trades at $26.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APDGX's P/E ratio is 20.36. In terms of profitability, MDLOX's ROE is N/A, compared to APDGX's ROE of N/A. Regarding short-term risk, MDLOX and APDGX have similar daily volatility (0.00).Check APDGX's competition here
MDLOX vs ARTGX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, ARTGX has a market cap of 2.7B. Regarding current trading prices, MDLOX is priced at $19.81, while ARTGX trades at $26.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas ARTGX's P/E ratio is 20.35. In terms of profitability, MDLOX's ROE is N/A, compared to ARTGX's ROE of N/A. Regarding short-term risk, MDLOX and ARTGX have similar daily volatility (0.00).Check ARTGX's competition here
MDLOX vs APHGX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, APHGX has a market cap of 2.7B. Regarding current trading prices, MDLOX is priced at $19.81, while APHGX trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas APHGX's P/E ratio is 20.79. In terms of profitability, MDLOX's ROE is N/A, compared to APHGX's ROE of N/A. Regarding short-term risk, MDLOX and APHGX have similar daily volatility (0.00).Check APHGX's competition here
MDLOX vs SGTTX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, SGTTX has a market cap of 2.7B. Regarding current trading prices, MDLOX is priced at $19.81, while SGTTX trades at $87.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGTTX's P/E ratio is 29.01. In terms of profitability, MDLOX's ROE is N/A, compared to SGTTX's ROE of N/A. Regarding short-term risk, MDLOX and SGTTX have similar daily volatility (0.00).Check SGTTX's competition here
MDLOX vs CSGZX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CSGZX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while CSGZX trades at $86.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CSGZX's P/E ratio is 29.01. In terms of profitability, MDLOX's ROE is N/A, compared to CSGZX's ROE of N/A. Regarding short-term risk, MDLOX and CSGZX have similar daily volatility (0.00).Check CSGZX's competition here
MDLOX vs MSFLX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, MSFLX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while MSFLX trades at $34.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MSFLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MSFLX's ROE of N/A. Regarding short-term risk, MDLOX and MSFLX have similar daily volatility (0.00).Check MSFLX's competition here
MDLOX vs MSFBX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, MSFBX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while MSFBX trades at $34.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MSFBX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MSFBX's ROE of +0.42%. Regarding short-term risk, MDLOX and MSFBX have similar daily volatility (0.00).Check MSFBX's competition here
MDLOX vs JORIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JORIX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while JORIX trades at $20.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORIX's P/E ratio is 2.68. In terms of profitability, MDLOX's ROE is N/A, compared to JORIX's ROE of N/A. Regarding short-term risk, MDLOX and JORIX have similar daily volatility (0.00).Check JORIX's competition here
MDLOX vs MLPX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, MLPX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while MLPX trades at $60.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MLPX's P/E ratio is 18.24. In terms of profitability, MDLOX's ROE is N/A, compared to MLPX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MLPX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check MLPX's competition here
MDLOX vs JORAX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JORAX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while JORAX trades at $20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORAX's P/E ratio is 2.68. In terms of profitability, MDLOX's ROE is N/A, compared to JORAX's ROE of N/A. Regarding short-term risk, MDLOX and JORAX have similar daily volatility (0.00).Check JORAX's competition here
MDLOX vs JORFX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JORFX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while JORFX trades at $20.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORFX's P/E ratio is 2.67. In terms of profitability, MDLOX's ROE is N/A, compared to JORFX's ROE of N/A. Regarding short-term risk, MDLOX and JORFX have similar daily volatility (0.00).Check JORFX's competition here
MDLOX vs JORNX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JORNX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while JORNX trades at $20.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORNX's P/E ratio is 2.67. In terms of profitability, MDLOX's ROE is N/A, compared to JORNX's ROE of N/A. Regarding short-term risk, MDLOX and JORNX have similar daily volatility (0.00).Check JORNX's competition here
MDLOX vs JSLNX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JSLNX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while JSLNX trades at $20.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JSLNX's P/E ratio is 2.66. In terms of profitability, MDLOX's ROE is N/A, compared to JSLNX's ROE of N/A. Regarding short-term risk, MDLOX and JSLNX have similar daily volatility (0.00).Check JSLNX's competition here
MDLOX vs CCHRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, CCHRX has a market cap of 2.6B. Regarding current trading prices, MDLOX is priced at $19.81, while CCHRX trades at $87.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas CCHRX's P/E ratio is 27.66. In terms of profitability, MDLOX's ROE is N/A, compared to CCHRX's ROE of N/A. Regarding short-term risk, MDLOX and CCHRX have similar daily volatility (0.00).Check CCHRX's competition here
MDLOX vs JORRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JORRX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.81, while JORRX trades at $20.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORRX's P/E ratio is 2.61. In terms of profitability, MDLOX's ROE is N/A, compared to JORRX's ROE of N/A. Regarding short-term risk, MDLOX and JORRX have similar daily volatility (0.00).Check JORRX's competition here
MDLOX vs DFGR Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, DFGR has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.81, while DFGR trades at $27.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas DFGR's P/E ratio is 26.04. In terms of profitability, MDLOX's ROE is N/A, compared to DFGR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DFGR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check DFGR's competition here
MDLOX vs VGWLX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, VGWLX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.81, while VGWLX trades at $27.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VGWLX's P/E ratio is 16.74. In terms of profitability, MDLOX's ROE is N/A, compared to VGWLX's ROE of +0.00%. Regarding short-term risk, MDLOX and VGWLX have similar daily volatility (0.00).Check VGWLX's competition here
MDLOX vs VGWAX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, VGWAX has a market cap of 2.5B. Regarding current trading prices, MDLOX is priced at $19.81, while VGWAX trades at $34.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VGWAX's P/E ratio is 16.74. In terms of profitability, MDLOX's ROE is N/A, compared to VGWAX's ROE of +0.00%. Regarding short-term risk, MDLOX and VGWAX have similar daily volatility (0.00).Check VGWAX's competition here
MDLOX vs JORCX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, JORCX has a market cap of 2.4B. Regarding current trading prices, MDLOX is priced at $19.81, while JORCX trades at $19.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas JORCX's P/E ratio is 2.49. In terms of profitability, MDLOX's ROE is N/A, compared to JORCX's ROE of N/A. Regarding short-term risk, MDLOX and JORCX have similar daily volatility (0.00).Check JORCX's competition here
MDLOX vs BIALX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, BIALX has a market cap of 2.4B. Regarding current trading prices, MDLOX is priced at $19.81, while BIALX trades at $29.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas BIALX's P/E ratio is 27.98. In terms of profitability, MDLOX's ROE is N/A, compared to BIALX's ROE of N/A. Regarding short-term risk, MDLOX and BIALX have similar daily volatility (0.00).Check BIALX's competition here
MDLOX vs OPGIX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, OPGIX has a market cap of 2.4B. Regarding current trading prices, MDLOX is priced at $19.81, while OPGIX trades at $49.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas OPGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to OPGIX's ROE of N/A. Regarding short-term risk, MDLOX and OPGIX have similar daily volatility (0.00).Check OPGIX's competition here
MDLOX vs SGTRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, SGTRX has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.81, while SGTRX trades at $76.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas SGTRX's P/E ratio is 29.00. In terms of profitability, MDLOX's ROE is N/A, compared to SGTRX's ROE of N/A. Regarding short-term risk, MDLOX and SGTRX have similar daily volatility (0.00).Check SGTRX's competition here
MDLOX vs GCOW Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, GCOW has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.81, while GCOW trades at $40.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas GCOW's P/E ratio is 13.86. In terms of profitability, MDLOX's ROE is N/A, compared to GCOW's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to GCOW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check GCOW's competition here
MDLOX vs PFFD Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, PFFD has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.81, while PFFD trades at $19.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas PFFD's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PFFD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PFFD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check PFFD's competition here
MDLOX vs FTGC Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, FTGC has a market cap of 2.3B. Regarding current trading prices, MDLOX is priced at $19.81, while FTGC trades at $25.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas FTGC's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FTGC's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FTGC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.Check FTGC's competition here
MDLOX vs IILGX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, IILGX has a market cap of 2.2B. Regarding current trading prices, MDLOX is priced at $19.81, while IILGX trades at $30.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas IILGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to IILGX's ROE of N/A. Regarding short-term risk, MDLOX and IILGX have similar daily volatility (0.00).Check IILGX's competition here
MDLOX vs MWEFX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, MWEFX has a market cap of 2.1B. Regarding current trading prices, MDLOX is priced at $19.81, while MWEFX trades at $47.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas MWEFX's P/E ratio is 23.36. In terms of profitability, MDLOX's ROE is N/A, compared to MWEFX's ROE of N/A. Regarding short-term risk, MDLOX and MWEFX have similar daily volatility (0.00).Check MWEFX's competition here
MDLOX vs VMVFX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, VMVFX has a market cap of 2.1B. Regarding current trading prices, MDLOX is priced at $19.81, while VMVFX trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VMVFX's P/E ratio is 21.60. In terms of profitability, MDLOX's ROE is N/A, compared to VMVFX's ROE of +0.00%. Regarding short-term risk, MDLOX and VMVFX have similar daily volatility (0.00).Check VMVFX's competition here
MDLOX vs VMNVX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, VMNVX has a market cap of 2.1B. Regarding current trading prices, MDLOX is priced at $19.81, while VMNVX trades at $33.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas VMNVX's P/E ratio is 21.61. In terms of profitability, MDLOX's ROE is N/A, compared to VMNVX's ROE of +0.00%. Regarding short-term risk, MDLOX and VMNVX have similar daily volatility (0.00).Check VMNVX's competition here
MDLOX vs ARTRX Comparison August 2025
MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDLOX stands at 16.5B. In comparison, ARTRX has a market cap of 2.1B. Regarding current trading prices, MDLOX is priced at $19.81, while ARTRX trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDLOX currently has a P/E ratio of N/A, whereas ARTRX's P/E ratio is 36.83. In terms of profitability, MDLOX's ROE is N/A, compared to ARTRX's ROE of N/A. Regarding short-term risk, MDLOX and ARTRX have similar daily volatility (0.00).Check ARTRX's competition here